SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 155 filers reported holding SAGE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $4,231,800 | -61.7% | 90,000 | -76.6% | 0.37% | -68.5% |
Q1 2020 | $11,057,000 | -33.4% | 385,000 | +67.4% | 1.17% | -23.1% |
Q4 2019 | $16,604,000 | -100.0% | 230,000 | -42.5% | 1.53% | -73.7% |
Q3 2019 | $56,116,000,000 | -23.4% | 400,000 | 0.0% | 5.81% | -15.3% |
Q2 2019 | $73,236,000,000 | +115014.7% | 400,000 | 0.0% | 6.86% | -1.9% |
Q1 2019 | $63,620,000 | +112.9% | 400,000 | +28.2% | 6.99% | +36.7% |
Q4 2018 | $29,886,000 | -32.2% | 312,000 | 0.0% | 5.11% | -4.5% |
Q3 2018 | $44,070,000 | +12.6% | 312,000 | +24.8% | 5.36% | -2.1% |
Q2 2018 | $39,133,000 | -2.8% | 250,000 | 0.0% | 5.47% | -22.7% |
Q1 2018 | $40,268,000 | -2.2% | 250,000 | 0.0% | 7.08% | -29.4% |
Q4 2017 | $41,178,000 | +175.4% | 250,000 | +4.2% | 10.03% | +137.5% |
Q3 2017 | $14,952,000 | -26.4% | 240,000 | -5.9% | 4.22% | -43.8% |
Q2 2017 | $20,308,000 | +12.1% | 255,000 | 0.0% | 7.51% | -29.7% |
Q1 2017 | $18,123,000 | +36.8% | 255,000 | -1.7% | 10.69% | -2.3% |
Q4 2016 | $13,250,000 | +8.0% | 259,500 | -2.6% | 10.94% | +10.1% |
Q3 2016 | $12,272,000 | +38.8% | 266,500 | -9.2% | 9.94% | +12.9% |
Q2 2016 | $8,843,000 | +45.9% | 293,500 | +55.3% | 8.80% | +26.6% |
Q1 2016 | $6,059,000 | -27.3% | 189,000 | +32.2% | 6.95% | -5.6% |
Q4 2015 | $8,338,000 | – | 143,011 | – | 7.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |